[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2920967B1 - Utilisation de l'hydroxymethionine en tant qu'actif anti age - Google Patents

Utilisation de l'hydroxymethionine en tant qu'actif anti age

Info

Publication number
FR2920967B1
FR2920967B1 FR0757616A FR0757616A FR2920967B1 FR 2920967 B1 FR2920967 B1 FR 2920967B1 FR 0757616 A FR0757616 A FR 0757616A FR 0757616 A FR0757616 A FR 0757616A FR 2920967 B1 FR2920967 B1 FR 2920967B1
Authority
FR
France
Prior art keywords
hydroxymethionine
aging agent
aging
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0757616A
Other languages
English (en)
Other versions
FR2920967A1 (fr
Inventor
Karl Lintner
Chamberlin Claire Mas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR0757616A priority Critical patent/FR2920967B1/fr
Priority to JP2010524614A priority patent/JP5209724B2/ja
Priority to US12/733,557 priority patent/US8377663B2/en
Priority to EP08807602.1A priority patent/EP2209460B1/fr
Priority to CN200880108024.1A priority patent/CN101854907B/zh
Priority to PCT/IB2008/053667 priority patent/WO2009034537A2/fr
Publication of FR2920967A1 publication Critical patent/FR2920967A1/fr
Application granted granted Critical
Publication of FR2920967B1 publication Critical patent/FR2920967B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0757616A 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age Active FR2920967B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0757616A FR2920967B1 (fr) 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age
JP2010524614A JP5209724B2 (ja) 2007-09-14 2008-09-11 ヒドロキシメチオニン及び３−アミノプロパンスルホン酸を含む化粧品組成物
US12/733,557 US8377663B2 (en) 2007-09-14 2008-09-11 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid
EP08807602.1A EP2209460B1 (fr) 2007-09-14 2008-09-11 Composition cosmétique comprenant de l'hydroxyméthionine et de l'acide 3-aminopropanesulfonique
CN200880108024.1A CN101854907B (zh) 2007-09-14 2008-09-11 化妆用或皮肤药用的组合物及其用法和化妆方法
PCT/IB2008/053667 WO2009034537A2 (fr) 2007-09-14 2008-09-11 Composition cosmétique comprenant de l'hydroxyméthionine et de l'acide 3-aminopropanesulfonique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0757616A FR2920967B1 (fr) 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age

Publications (2)

Publication Number Publication Date
FR2920967A1 FR2920967A1 (fr) 2009-03-20
FR2920967B1 true FR2920967B1 (fr) 2009-10-23

Family

ID=39338384

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0757616A Active FR2920967B1 (fr) 2007-09-14 2007-09-14 Utilisation de l'hydroxymethionine en tant qu'actif anti age

Country Status (6)

Country Link
US (1) US8377663B2 (fr)
EP (1) EP2209460B1 (fr)
JP (1) JP5209724B2 (fr)
CN (1) CN101854907B (fr)
FR (1) FR2920967B1 (fr)
WO (1) WO2009034537A2 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843023B1 (fr) * 2002-07-30 2004-09-24 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2869229B1 (fr) * 2004-04-26 2006-08-25 Sederma Soc Par Actions Simpli Utilisation d'un inducteur des ugt par voie topique
FR2880802B1 (fr) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
FR2904549B1 (fr) 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
GB0910657D0 (en) 2009-06-22 2009-08-05 Unilever Plc Antiperspirant compositions
CN103429748B (zh) 2010-12-30 2016-01-06 代谢探索者公司 甲硫氨酸羟基类似物(mha)的发酵产生
DE102011078952A1 (de) * 2011-07-11 2013-01-17 Henkel Ag & Co. Kgaa Pflegendes kosmetisches Reinigungsmittel mit verbesserten Schaumeigenschaften
BR112014023379A8 (pt) * 2012-03-22 2017-07-25 Prec Dermatology Inc Microemulsões com base em ciclodextrina e usos dermatológicos das mesmas
IN2014DN09937A (fr) 2012-05-30 2015-08-14 Clariant Int Ltd
EP2854751B1 (fr) 2012-05-30 2016-08-10 Clariant International Ltd. Utilisation de n-méthyl-n-acylglucamines comme solubilisants
JP2014040398A (ja) * 2012-08-23 2014-03-06 Mikimoto Pharmaceut Co Ltd フィラグリン産生促進剤、インボルクリン産生促進剤、ロリクリン産生促進剤、コルネオデスモシン産生促進剤他
DE102012021647A1 (de) 2012-11-03 2014-05-08 Clariant International Ltd. Wässrige Adjuvant-Zusammensetzungen
CN102988199B (zh) * 2012-11-30 2014-05-07 唯美度科技（北京）有限公司 嫩肤抗敏精华液
US9861645B2 (en) 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
JP2014208597A (ja) * 2013-04-16 2014-11-06 オリザ油化株式会社 爪におけるセラミド含量増加剤
CN105263582B (zh) * 2013-04-20 2018-12-21 克拉里安特国际有限公司 包含油体、脂肪酸、氨基酸表面活性剂和n-甲基-n-酰基葡糖胺的组合物
DE102014005771A1 (de) 2014-04-23 2015-10-29 Clariant International Ltd. Verwendung von wässrigen driftreduzierenden Zusammensetzungen
US20170312207A1 (en) * 2014-11-10 2017-11-02 Showa Denko K.K. Moisturizing agent
US20180110804A1 (en) * 2015-02-04 2018-04-26 Nugene, Inc. Burn, scar, and wound treatment creams
KR102359434B1 (ko) * 2015-03-31 2022-02-09 (주)아모레퍼시픽 피부보습용 조성물
JP6666992B2 (ja) * 2015-07-13 2020-03-18 ドクター・レディーズ・ラボラトリーズ・リミテッド 局所用レチノイド組成物
US10772820B2 (en) * 2015-07-22 2020-09-15 L'oreal Composition for cleansing a keratin material containing an amino acid surfactant
DE102015219608B4 (de) 2015-10-09 2018-05-03 Clariant International Ltd Universelle Pigmentdispersionen auf Basis von N-Alkylglukaminen
DE102015219651A1 (de) 2015-10-09 2017-04-13 Clariant International Ltd. Zusammensetzungen enthaltend Zuckeramin und Fettsäure
JP6703824B2 (ja) * 2015-11-30 2020-06-03 シスメックス株式会社 細胞選択方法、細胞検出方法、細胞選択装置、および細胞検出装置
DE102016207877A1 (de) 2016-05-09 2017-11-09 Clariant International Ltd Stabilisatoren für Silikatfarben
GB201611406D0 (en) * 2016-06-30 2016-08-17 Boots Co Plc Skin care composition and method thereof
GB201611413D0 (en) * 2016-06-30 2016-08-17 Boots Co Plc Method of skin care
US20210161870A1 (en) 2017-06-07 2021-06-03 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US12011437B1 (en) 2017-06-07 2024-06-18 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US11129818B2 (en) 2017-06-07 2021-09-28 Arcutis Biotherapeutics, Inc. Topical roflumilast formulation having improved delivery and plasma half life
US9895359B1 (en) 2017-06-07 2018-02-20 Arcutis, Inc. Inhibition of crystal growth of roflumilast
MX2020013192A (es) 2018-06-04 2021-08-16 Arcutis Inc Metodo y formulacion para mejorar el tiempo de retraso de penetracion en la piel de roflumilast.
MX2021015351A (es) * 2019-06-24 2022-04-07 Rossana Castellana Formulaciones para uso odontologico y dermatologico que contienen sales de tricloroacetato e hidroxiacidos.
FR3107120B1 (fr) * 2020-02-07 2022-11-25 Rubix S&I Procédé et système d’étalonnage d’un capteur chimique non sélectif
JP7437503B2 (ja) * 2020-05-07 2024-02-22 アーキュティス・バイオセラピューティクス・インコーポレーテッド 高クラフト温度アニオン性界面活性剤を使用した皮膚症状の処置
CN111973528B (zh) * 2020-08-27 2022-07-01 上海辉文生物技术股份有限公司 一种具有美白抗炎安全不致敏的薯蓣提取物及其制备方法
WO2024058848A1 (fr) 2022-09-15 2024-03-21 Arcutis Biotherapeutics, Inc. Compositions pharmaceutiques de roflumilast et de solvants capables de dissoudre des quantités élevées de médicament
CN117598924B (zh) * 2023-11-30 2024-06-18 广州市仙迪生物科技有限公司 一种植物多肽组合物及其应用
CN117679328B (zh) * 2023-12-14 2025-01-24 山东福瑞达生物股份有限公司 一种具有修护功效的液晶泥膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
MC2394A1 (fr) * 1995-05-24 1996-07-26 Mollet Marc Composition destinée à stopper la chute et/ou à favoriser
KR0162281B1 (ko) * 1995-10-27 1998-12-01 이능희 타우린 및 아미노프로판 설폰산 또는 그의 염을 함유하는 화장료 조성물
DE10133197A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US20040126449A1 (en) * 2002-12-30 2004-07-01 Gopa Majmudar Topical composition and methods for treatment of aged or environmentally damaged skin

Also Published As

Publication number Publication date
CN101854907A (zh) 2010-10-06
WO2009034537A2 (fr) 2009-03-19
EP2209460B1 (fr) 2017-05-10
WO2009034537A3 (fr) 2010-02-25
FR2920967A1 (fr) 2009-03-20
US8377663B2 (en) 2013-02-19
JP5209724B2 (ja) 2013-06-12
US20100285077A1 (en) 2010-11-11
JP2010539157A (ja) 2010-12-16
EP2209460A2 (fr) 2010-07-28
CN101854907B (zh) 2014-06-18

Similar Documents

Publication Publication Date Title
FR2920967B1 (fr) Utilisation de l'hydroxymethionine en tant qu'actif anti age
EP2512246A4 (fr) Aminopyrimidines en tant qu'inhibiteurs de la syk
EP2398483A4 (fr) Analogues de l'oxyntomoduline
BRPI0910229A2 (pt) Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BRPI1008178A2 (pt) "descarga de baterias"
FR2951946B1 (fr) Utilisation d'un hydrolysat peptidique de levure en tant qu'agent actif pour renforcer le cheveu
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
FR2940290B1 (fr) Agent de couplage mercaptosilane bloque
EP2217716A4 (fr) Utilisation d'inhibiteurs de récepteurs tam en tant qu'antimicrobiens
EP2475675A4 (fr) Modulation de l'expression de la huntingtine
EP2200550A4 (fr) Formulations topiques de glycopyrrolate
EP2297585A4 (fr) Détection de l' usage de cannabis
BRPI0913806A2 (pt) "composição"
ME02979B (fr) Compositions d'hémoglobine
BRPI1015540A2 (pt) ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
BRPI0907268A2 (pt) "seringa de segurança"
EP2127646A4 (fr) Agent pour soulager ou prévenir la xérostomie
DK2185142T3 (da) Antiseptiske midler
BRPI0916129A2 (pt) "reforço"
BR112012025270A2 (pt) "composição de cuidados pessoais"
BRPI0914383A2 (pt) "composição de shampoo condicionador"
BRPI0914503A2 (pt) "composição de shampoo concentrado"
DK2237727T3 (da) Vævsretraktor
EP2438217A4 (fr) Nanostructures d'or electrodeposeess
EP2461805A4 (fr) Spectinamides en tant qu agents antituberculeux

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18